Evidence map›Paper›PMID 35736168›Full record

ArticleMarine drugs2022

Protein Hydrolysate from

Chi-Woo Lee, Yeok Boo Chang, Chun Woong Park, Sung Hee Han, Hyung Joo Suh, Yejin Ahn

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Protective Efficacy ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Beneficial effects ofFood science and biotechnology · 2025
    Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chi-Woo LeeDepartment of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul 02841, Korea.
Yeok Boo ChangDepartment of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul 02841, Korea.
Chun Woong ParkDepartment of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul 02841, Korea.
Sung Hee HanInstitute of Human Behavior & Genetic, College of Medicine, Korea University, Seoul 02841, Korea.
Hyung Joo SuhDepartment of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul 02841, Korea.ORCID 0000-0001-8869-3929
Yejin AhnDepartment of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul 02841, Korea.ORCID 0000-0002-7016-9798
Korea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loss of muscle mass is the primary symptom of sarcopenia. Protein intake is recommended to prevent muscle mass loss, and

Indexed as

SpirulinaDexamethasoneForkhead Box Protein O3HumansMuscle Fibers, SkeletalMuscle, SkeletalMuscular AtrophyProtein HydrolysatesProto-Oncogene Proteins c-aktDexamethasoneForkhead Box Protein O3FOXO3 protein, humanProtein HydrolysatesProto-Oncogene Proteins c-aktCollupulindexamethasonemuscle atrophySpirulina

Identifiers

PMID35736168
PMCPMC9229963
OpenAlexW4281755890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.